I was curious about how administering a cytokine could improve survival, especially since there's evidence of cytokine storm in severe cases. A cursory look on

I was curious about how administering a cytokine could improve survival, especially since there's evidence of cytokine storm in severe cases. A cursory look on wikipedia[1]: > Since there is evidence that insufficient production of interferon beta-1a in lung cells in older people can lead to their increased susceptibility to respiratory viral infections such as SARS-CoV-2 and MERS-CoV, replenishing the deficiency of this interferon can protect against the dire effects of these diseases. Company Synairgen began clinical tests of SNG001, a special inhalation formulation of interferon beta-1a in patients with COVID-19 So it sounds like this treatment (assuming it is effective) would only be especially effective in older people (or younger people with some kind of Interferon beta-1-a deficiency I guess), and only if administered relatively early in the course of the disease - i.e. before development of pneumonia. 1: https://en.wikipedia.org/wiki/Interferon_beta-1a#Clinical_trials https://en.wikipedia.org/wiki/Interferon_beta-1a#Clinical_tr...